Title : Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.

Pub. Date : 2016 Jul

PMID : 27241260






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Given these findings, we hypothesize that, in at-risk individuals (those with obesity-induced inflammation and metabolic dysregulation), long-term colchicine use will lead to suppression of inflammation and thus cause improvements in insulin sensitivity and other obesity-related metabolic impairments. Colchicine insulin Homo sapiens